Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 Study of ChoironeX GalKO Porcine Thymokidney Xenotransplantation in End-Stage Renal Disease

NCT07696962 is registered in ClinicalTrials.gov with Xeno Holdings (US), LLC dba ChoironeX as lead sponsor.

NCT NCT07696962
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07696962 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 Study of ChoironeX GalKO Porcine Thymokidney Xenotransplantation in End-Stage Renal Disease
Lead sponsor
Xeno Holdings (US), LLC dba ChoironeX
Phase
Phase 1
Overall status
Not yet recruiting
Start date
September 30, 2026
Completion date
September 30, 2028
Enrollment
4 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

end stage renal disease